The Cross-Border Biotech Blog

Biotechnology, Health and Business in Canada, the United States and Worldwide

Category Archives: This Week in the Twitterverse

This Week in the Twitterverse

Here’s some reading for the weekend in case you missed these items the first time around on @crossborderbio: Introduction of Private Member’s Bill to add genetic characteristics to the Human Rights Act http://bit.ly/dhwbyp via @mikesgene  RT @genomicslawyer @genetics_blog Colbert on gene patenting http://bit.ly/bx37kQ Note 2 ACLU: Don’t make enemies with the ppl who own cancer  New [...]

This Week in the Twitterverse

Here’s some reading for the weekend in case you missed them the first time around on @crossborderbio: FDA to hold public hearing Monday for PDUFA comments. Announcement and background webinar at http://bit.ly/cs66xY Obama appoints 12 to bioethics commission for “practical, policy-oriented, ethics-based” advice. http://go.usa.gov/iWp via @whitehouseostp RT @TechLaw_Elman: PBS Newshour: Superb report of the debate on [...]

This Week in the Twitterverse

It was a quiet week on the blog (confluence of holidays), but here are some good tidbits to catch up on over the weekend in case you missed them the first time around on @crossborderbio: RT @GenomeWeb_News: White House Seeks Comments on Translating Federal R&D http://tinyurl.com/yzpanec 2 days ago RT @dgmacarthur: Genetic Future post: Nature special issue [...]

This Week in the Twitterverse

Here are some good tidbits to catch up on over the weekend in case you missed them the first time around on @crossborderbio: Most enjoyable CLE ever — http://www.ipcolloquium.com/ — thanks DGL (@doug_lichtman )! RT @FDAcdrhIndustry: Online presentation: Good Clinical Practice 101 http://bit.ly/akRkIo #fda #medicaldevice  New Post: Friday Science Review: March 26, 2010 – Why [...]

This Week in the Twitterverse

Here are some good tidbits to catch up on over the weekend in case you missed them the first time around on @crossborderbio: RT @JohnCFierce: In followup on the FDA’s new approach to cocktail drugs … a new TB collaboration. Reuters: http://bit.ly/dg1XCj 1 day ago Medicago (TSXV $MDG) sees $1.6m from exercise of 99% of warrants from [...]

This Week in the Twitterverse

Here are a few tidbits to catch up on over the weekend from  @crossborderbio.  Back to full capacity next week. RT @genomicslawyer: FDA Announces New Warning for Plavix linked to genotype http://bit.ly/9LdAVR (HT @GeneSherpas) 13 hours ago Agrium to terminate CF offer http://bit.ly/9SNyPb RT @AHCJ_Pia: RT @marynmck: RT @setonh1n1: Canadian Press reports 17x increase in MRSA in Canada between [...]

This Week in the Twitterverse: Weekend Reading

This week was full of news and analysis from the federal budget, so check that out by clicking here. When you’re done with that, here are some other good tidbits to catch up on over the weekend in case you missed them the first time around on @crossborderbio: RT @FDAcdrhIndustry: Deadline for commenting on 510(k) [...]

This Week in the Twitterverse: Weekend Reading

Here are some good tidbits to catch up on over the weekend in case you missed them the first time around on @crossborderbio: RT @Equicom: NEWS: ConjuChem Files for Restructuring. http://bit.ly/aNfuWC 18 hours ago @randypicker Student: 24-0. Securities lawyer: past performance not= future results. Canadian: Better get a new calculator by Sunday! 20 hours ago As long as whole-genome [...]

This Week in the Twitterverse: Weekend Reading

Here are some good tidbits to catch up on over the weekend in case you missed them the first time around on @crossborderbio: RT @ogilvyrenault: Convery and Chung contribute to @MaRSDD white paper on legal innovations in social entrepreneurship http://bit.ly/amRrY4  Oncothyreon $ONTY signs $8.4m SIFT/SR&ED arrangement http://bit.ly/981bBO like SemBioSys, ConjuChem, Vasogen http://bit.ly/cBL2qV  Labopharm closes $20m [...]

This Week in the Twitterverse: Weekend Reading

Here are some good tidbits to catch up on over the weekend in case you missed them the first time around on @crossborderbio: RT @SternIR @ldtimmerman Biotech heavy hitters Westphal,Dipp,Aldrich start new fund. Track record speaks for itself http://xrl.us/bgvu9x RT @PharmProEditor: Bioniche Achieves Two Additional Milestones Under Endo Licensing Agreement http://bit.ly/9Zut0N RT @FierceBiotech: Melnyk’s Trimel [...]

This Week in the Twitterverse: Weekend Reading

Here are some good tidbits to catch up on over the weekend in case you missed them the first time around on @crossborderbio: RT @ogilvyrenault: New Insider Reporting Regime to Take Effect in Canada http://bit.ly/bmAUJq 1 day ago Progeria Research Found’n, heavily involved in commercialization, completes trial enrollment with ARRA/NIH funding http://bit.ly/bt4ter 1 day ago TSX Venture Exchange Announces [...]

This Week in the Twitterverse: Weekend Reading

Catch up on all the Canadian biotech news that caught our eyes this week: CAMH out-licenses to Athena Diagnostics in MA to develop genetic test for muscle disorders caused by FHL1 mutations http://bit.ly/cTSUrd  Ontario Hospital Association & PharmaTrust Partner on telepharmacy prescription-dispensing kiosks in hospitals http://bit.ly/c0wlXG  Congrats to winners of CNA-CMA 2010 Media Awards for [...]

This Week in the Twitterverse: Weekend Reading

Lots of good info from Twitter this week.  Catch up on all the news that’s too brief to print: RT @AHCJ_Pia: Data.gov just released data sets called for by Open Govt Directive – Incl food, health, VA, enviro data. http://data.gov/ogd RT @dgmacarthur: Genetic Future post: Personal genomics is getting serious: Counsyl emerging from stealth mode [...]

This Week in the Twitterverse

This week was full of interesting developments — catch up with some weekend reading from @crossborderbio: Great new VC blog – really smart stuff from Peter Carrescia at http://techdisruptions.com/ #vc #blog 19 hours ago WSJ VC Blog sums up #JPM10 http://viigo.im/25Ba 23 hours ago Friday Science Review: January 15, 2010 – A little sunflower power to brighten up a [...]

This Week in the Twitterverse

A busy week this week on Twitter, so if you don’t follow us at @crossborderbio, here’s your weekend remedial reading: RT @mrcglobal: From the Economist: Innovation in global health – A spoonful of ingenuity http://bit.ly/7R2Lfy 1 day ago RT @PharmProEditor: MDS Appoints Steve West MDS Inc. CEO – Peter Dans Appointed Future CFO http://bit.ly/7LSIH5 1 day ago Good stuff! [...]

This Week in the Twitterverse

Some interesting bits from the business side and the science side from @crossborderbio on Twitter: Transgenic prairie voles set the stage to investigate the genetics of monogamy. Stay tuned… http://viigo.im/1WD9 22 hours ago Congratulations to #CLawBies2009 winners and other runners-up (runner-ups? finalists?)! Thanks @stevematthews and @jordan_law21!! 23 hours ago Forbes picks Monsanto as company of the year, writes up [...]

This Week in the Twitterverse

This week was not so quiet in the world of biotech, despite my mostly successful attempts at vacation.  Here are some highlights from our Twitter stream @crossborderbio for you to catch up on: AstraZeneca Pays Up to $425 Million for Novexel (from NYT DealBook) http://viigo.im/1TfK 1 day ago Good summary of year-end #biotech #pharma deals http://viigo.im/1Tfz 1 day ago [...]

This Week in the Twitterverse

Things to read this weekend if you aren’t following us on Twitter @crossborderbio… That’s bound to help. CBO estimates new #senate #hcr bill reduces deficit by $132b in 1st 10 yrs http://bit.ly/6Ue1T9 18 hours ago @jensmccabe most interesting take-away from attractiveness study is a take-along..everyone bring a ruler to ur haircut! http://bit.ly/8RmvMb 1 day ago Next IPO to watch [...]

This Week in the Twitterverse

A busy week for @crossborderbio on Twitter.  Here’s what you may have missed: RT @FiercePharma: BusinessWeek: Drug maker Patheon to close or sell PR plant. http://bit.ly/5bVqog RT @CLSD: Carleton U Prof. finds new way to repair damaged nerves http://bit.ly/6DjSd6 + more cool Canadian #science at http://ow.ly/168yJn  RT @genomicslawyer: Regulations to Implement GINA Move One Step [...]

This Week in the Twitterverse

For those who don’t follow us on Twitter @crossborderbio, here are this week’s short, but notable, developments: Globe and Mail article criticizes Canadian absence of Oncotype DX test (21-locus personalized breast cancer expression) http://bit.ly/65baVw 3 hours ago Æterna Zentaris’ Perifosine Receives Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma http://bit.ly/5CTZBV 2 days ago RT @RICCentre: Register for [...]

This Week in the Twitterverse

A pretty quiet week for @crossborderbio on Twitter.  The first part was consumed by a tech deal of some magnitude, and the second part was U.S. Thanksgiving.  Nevertheless, a few tweets escaped: Good update/summary from the WSJ on the status of #biosimilars exclusivity in #hcr legislation http://bit.ly/4oYmbd 1 day ago Congrats! RT @fodden: RT @slaw_dot_ca Slaw hits [...]

This Week in the Twitterverse

Tweets of the week, in case you don’t follow us @crossborderbio: Cool story by my wife/editor about evolutionary advantages for sensitive kids @jenniferkolari ‘s Blog: http://ow.ly/DWd9 1 day ago RT @InVivoBlogEllen: NICE … tells Onyx/Bayer Nexavar is too pricey. Who doubts reimbursement = new deal hurdle? http://tinyurl.com/y86hq6c 1 day ago Quoted by Lexpert on Social Media http://ow.ly/162Y9H 1 day ago Boarding [...]

This Week in the Twitterverse

Tweets from the week – little bits of biotech goodness, reproduced here from @crossborderbio for your viewing pleasure: Agrium ($AGU) letter to $CF Industries shareholders lays out the case for Agrium’s bid. http://bit.ly/3bRR5r << $4.9b deal, #Canadian buyer 2 days ago RT @MaRSDD: Blog – Canada’s science policy takes centre stage in Toronto http://bit.ly/wNVjI #cspc 2 days ago RT [...]

This Week in the Twitterverse

For those who don’t follow @crossborderbio and for those who just like everything wrapped up nice and neatly in one post, here’s the Twitter news from the week.  Also, if you’re interested, I made a Twitter list of great Biopharma, HealthIT and Health twits.  Check it out here. RT @FierceBiotech: Reuters: Bioniche gets $6M milestone [...]

This Week in the Twitterverse

A lot of my tweeting this week was live reporting/commentary/snark from the first ever Canadian Science Policy Conference. The conference was a great success and will hopefully spur continued reflection and action in the coming months.  The highlight for me was moderating a panel on commercialization comprising Tom Brzustowski, Ronald Dyck, Jorge Niosi and Mark Romoff. [...]

This Week in the Twitterverse

Interesting items this week that were too short for their own post: Prep session with my panelists tomorrow morning for next week’s Science Policy Conference! http://sciencepolicy.ca/ Part of healthymagination RT @FierceBiotech GE launches $250M life sciences VC fund, extends pact with Lilly. http://is.gd/4vX3T #Health #Canada approves $GSK #swineflu #H1N1 #vaccine, delivery to provinces in progress [...]

This Week in the Twitterverse

Tweets we tweeted this week, in case you don’t follow us on Twitter.  Here’s what you missed: RT @ogilvyrenault: #Canada Signs Three New PPH Pilot Program Agreements http://bit.ly/2ldtnT << PPH = #Patent Prosecution Highway RT @randypicker: #rpatf09 Update on reverse payments for Hatch-Waxman generics: http://bit.ly/3gy3Q2  Institute for Chemicals and Fuels from Alternate Resources (ICFAR) opens today [...]

This Week in the Twitterverse

Tweets I tweeted this week @crossborderbio: RT @jensmccabe: CCHIT announces ‘modular’ EHR certification http://tinyurl.com/ykj9shz This week’s Friday Science Review: cancer, genomics and Nobels, oh my! http://bit.ly/kUkhN << Richard Chan, ladies and gents. RT @FierceBiotech: Kansas looks to boost early stage drug dev with $50M in venture capital funding. http://is.gd/46Qak << incl. Burrill,MPM Big news in [...]

This Week in the Twitterverse

Tweets I tweeted @crossborderbio.  Lots of stuff that’s worth knowing but is too short to get its own post: HHS proposed rule modifies the HIPAA Privacy Rule to cover genetic info pursuant to GINA http://bit.ly/19w0Pf via @GenomeWeb_News link to Tweet RT @CVCACanada: 20 Most Active Venture Capital Investors in Canada http://ow.ly/sp2c via @techvibes link to Tweet [...]

This Week in the Twitterverse

Here’s what I was Tweeting this week @crossborderbio: RT: @srinaldi Canadian Open Source EMR http://bit.ly/3y1tKM available for download at SourceForge. RT @CVCACanada: New Funds: The $100M Alberta Enterprise Corp. – Fund of Funds – is launched, Rod Charko joins as CEO RT @GenomeWeb_News: OGI Launches Genomics Platform Affiliates Program http://bit.ly/RJOkF Ontario gov’t puts $13.6m in [...]

Follow

Get every new post delivered to your Inbox.

Join 92 other followers